Loading…
Loading…
VRTX · NASDAQ · Healthcare
“When you find a company turning scientific breakthroughs into steady profits like Vertex does, paying thirty times earnings isn't unreasonable for such rare medicine-making prowess.”
— In the voice of Buffett
Calculate total returns over 1, 3, 5, and 10-year periods. Understand long-term compounding and investment outcomes.
Market Cap
$114.58B
P/E Ratio
28.98
Forward P/E
—
EPS
$15.46
PEG Ratio
0.88
Book Value
$73.00
Dividend Yield
—
Profit Margin
32.94%
ROE
21.18%
Use the interactive multi-year return with pre-loaded data for Vertex Pharmaceuticals Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for VRTX: